United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Technology Industry News Nasdaq gives Nuvini a second chance. Will SaaS investors give it one too? Find out how Nuvini (NASDAQ: NVNI) regained Nasdaq compliance and what its R$95M EBITDA guidance signals for Latin America’s SaaS consolidation game. byVenkateshOctober 20, 2025